Skip to main content
. 2020 May 23;9(5):1586. doi: 10.3390/jcm9051586

Table 3.

General characteristics of the studies included in the systematic review.

Authors, Year Study Design Population Mean Age in Years Periodontal Status Diagnostic Methods PCOS Diagnostic Methods Confounders Variables Assessed
Akcali A., 2014 [25] Case–control N = 125
PCOS-Healthy = 45
PCOS-Gingivitis = 20
Healthy-Controls = 25
Healthy-Gingivitis = 20
25.7 Oral examination, PD, PI, BOP, Work Shop 1999 criteria, saliva and serum samples Medical History
Rotterdam Criteria
Ultrasound
BMI > 30 kg/m2, hyperandrogenism, high BP, CVD, DM, hyperprolactinemia, congenital adrenal hyperplasia, thyroid disorder, Cushing’s syndrome, hepatic or renal dysfunction, oral contraceptives, steroid hormones, insulin-sensitizing medications
Akcali A., 2015 [26] Case–control N = 125
PCOS-Healthy = 45
PCOS-Gingivitis = 20
Healthy-Controls = 25
Healthy-Gingivitis = 20
25.7 Oral examination, PD, PI, BOP, Work Shop 1999 criteria, saliva and serum samples, MMP-8, MMP-I Medical History
Rotterdam Criteria
Ultrasound
Serum levels
BMI > 30 kg/m2, hyperandrogenism, high BP, CVD, DM, hyperprolactinemia, congenital adrenal hyperplasia, thyroid disorder, Cushing´s syndrome, hepatic or renal dysfunction, oral contraceptives, steroid hormones, insulin-sensitizing medications
Akcali A., 2017 [28] Case–control N = 125
PCOS-Healthy = 45
PCOS-Gingivitis = 20
Healthy-Controls = 25
Healthy-Gingivitis = 20
25.7 Oral examination, PD, PI, BOP, Work Shop 1999 criteria, saliva and serum samples Medical History
Rotterdam Criteria
Ultrasound
BMI > 30 kg/m2, hyperandrogenism, high BP, CVD, DM, hyperprolactinemia, congenital adrenal hyperplasia, thyroid disorder, Cushing´s syndrome, hepatic or renal dysfunction, oral contraceptives, steroid hormones, insulin-sensitizing medications
Deepti 2017 [30] Randomised controlled trail N = 60
PCOS = 30
Controls = 30
PCOS = 24.0
Controls = 22.6
Oral examination, PI, GI, BOP, PD, CAL Androgen Excess Society/2006 Criteria Nephrotic syndrome, chronic renal failure, significant CVD, diabetes mellitus, active cancer, smokers and alcohol dependent, antibiotics, oral contraceptives in the last 3 months, periapical pathology/inflammatory conditions, periodontal treatment within 6 months prior to study
Dursun E., 2011 [23] Case–control N = 52
PCOS-Non-obese = 25
Controls = 27
PCOS-non-obese = 22.7
Controls = 24.2
Oral examination, PD, CAL, GI, BOP, PI, Rx, GCF sample, Spectrophotometric, MPO assay Medical History
Rotterdam Criteria
Ultrasound
Serum levels
BMI > 30 kg/m2, hyperprolactinemia, congenital adrenal hyperplasia, thyroid disorder, Cushing´s syndrome, androgen-secreting tumours, smoking, oral contraceptives
Ozcaka O., 2012 [24] Case–control N = 73
PCOS-gingivitis = 30
PCOS-healthy = 31
Controls = 12
PCOS-gingivitis = 23.5
PCOS-healthy = 21.0
Controls = 28.5
Oral examination, PD, BOP, PI, saliva sample, GCF sample Medical History
Rotterdam Criteria
Ultrasound
Serum levels
Ferriman Gallwey score
BMI > 30 kg/m2, androgen-secreting tumours, congenital adrenal hyperplasia, thyroid disorders, DM, hyperprolactinemia, Cushing´s syndrome, high BP, hepatic and renal dysfunction, oral contraceptives, steroid hormones, insulin-sensitizing drugs, alcohol, smokers
Ozcaka O., 2013 [18] Case–control N = 73
PCOS-gingivitis = 30
PCOS-healthy = 31
Controls = 12
PCOS-gingivitis = 23.5
PCOS-healthy = 21.0
Controls = 28.5
Oral examination, PD, BOP, PI, saliva sample, GCF sample, Medical History
Rotterdam Criteria
Ultrasound
Serum levels
Ferriman Gallwey score
BMI > 30 kg/m2, hyperandrogenism, thyroid disorders, hyperprolactinemia, CVD, DM, high BP, oral contraceptives, steroid hormone, insulin-sensitizing drugs
Porwal S., 2014 [16] Case–control n = 126
PCOS = 41
PCOS-treatment = 45
Healthy controls = 40
PCOS = 23.1
PCOS-treatment = 22.7
Healthy controls = 23.5
Oral examination, PD, PI, BOP, CAL, GI Medical History
Rotterdam Criteria
Ultrasound
Serum levels
WC and WHR
hsCRP serum level
BMI > 30 kg/m2, thyroid disorders, hyperprolactinemia, androgen-secreting tumours, chronic inflammatory diseases, DM, CVD, cancer, smoking, alcohol, antibiotics, periodontal treatment, aggressive periodontitis
Rahimnejad ME., 2015 [27] Case–control n = 196
PCOS = 98
Healthy controls = 98
PCOS = 29.1
Healthy = 28.6
Oral examination, BOP, PD, CAL, PI, tooth loss
American Academy of Periodontology Criteria
Medical History
Rotterdam Criteria
Ultrasound
Serum levels
BMI > 25 kg/m2, pregnancy, osteoporosis, antibiotics, smoking, periodontal treatment, malignancies
Saglam E., 2017 [29] Case–control n = 88
PCOS without CP = 22
PCOS with CP = 22
Healthy with CP = 22
Healthy without CP = 22
PCOS without CP = 27.6
PCOS with CP = 28.6
Healthy with CP = 28.2
Healthy without CP = 27.8
Oral examination, PD, CAL, GI, PI, BOP
MDA level
8-OHdG level
TAS
Medical History
Rotterdam Criteria
Ultrasound
Serum levels
WC and WHR
BMI > 25 kg/m2, HbA1c > 6,5%, OGTT-2h > 200 mg/dL, not taken medication within the previous 3 months including antibiotics, oral contraceptives, steroid hormones, hypertensive medications, insulin-sensitizing drugs, periodontal therapy in the previous 6 months, androgen-secreting tumours, congenital adrenal hyperplasia, thyroid disorders, DM, hyperprolactinemia, Cushing´s syndrome

Abbreviations: BMI, body mass index; BOP, bleeding on probing; BP, blood pressure; CAL, clinical attachment loss; CVD, cardiovascular disease; DM, diabetes mellitus, GCF, gingival crevicular fluid; GI, gingival index; MDA, malondialdehyde; MMP, matrix metalloproteinase; MPO, myeloperoxidase; OGTT-2h, 2 h oral glucose tolerance test; 8-OHdG, hidroxi-deoxi-guanosina; PCOS, polycystic ovary syndrome; PI, plaque index; PD, probing depth; TAS, total antioxidant status.